-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalo Therapeutics CMO Mittie Doyle disposes of 679 common shares for $10,864

PUBT·06/01/2026 20:08:38
Listen to the news
Avalo Therapeutics CMO Mittie Doyle disposes of 679 common shares for $10,864
  • Avalo Therapeutics Chief Medical Officer Doyle Mittie exercised stock options for 679 shares at USD 8.04 on May 28.
  • He sold 679 shares at USD 16 in the same session.
  • Mittie ended the day with 47,122 shares of common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001918845-26-000016), on June 01, 2026, and is solely responsible for the information contained therein.